`
`In re Patent of:
`
`Lescallett et al.
`
`US. Patent No.:
`Issue Date:
`Appl. Serial No.:
`Filing Date:
`Title:
`
`6,051,379
`April 18, 2000
`08/984,034
`December 2, 1997
`CANCER SUSCEPTIBILITY MUTATIONS OF BRCA2
`
`Attorney Docket No.: 28496-0022lP1
`Case: |PR2014-O1313
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`US. Patent and Trademark Office
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`PATENT OWNER’S POWER OF ATTORNEY IN A POST GRANT PROCEEDINGS BEFORE THE
`PATENT TRIAL AND APPEAL BOARD
`
`Patent Owner, MYRIAD GENETICS, hereby appoints the following practitioners as its attorneys to
`
`transact all business in the United States Patent & Trademark Office associated with any inter partes
`
`review, covered business method review, post grant review, or other review proceedings before the Patent
`
`Trial and Appeal Board of the above-captioned patent:
`
`Dorothy P. Whelan, Reg. No. 33,814
`
`J. Patrick Finn lll, Reg. No. 44,109
`
`and all practitioners associated with PTO Customer Number 26171.
`
`i have the authority to execute this document on behalf of MYRIAD GENETICS
`
`MYRIAD GENETICS
`
`
`
`Title:
`Date:
`
`VP Legal Affairs
`LII/5 fl?
`
`.
`
`. .—
`
`